Annotation Detail

Information
Associated Genes
PIK3CD
Associated Variants
PIK3CD MUTATION
PIK3CD MUTATION
Associated Disease
chronic lymphocytic leukemia
Source Database
DisGeNET
Description
BCR signaling pathway inhibitors such as ibrutinib, idelalisib, and fostamatinib (respective inhibitors of Bruton's tyrosine kinase, PI3Kδ, and spleen tyrosine kinase) represent a significant therapeutic advance in B cell malignancies, including chronic lymphocytic leukemia (CLL).
Pubmed
25632006
Section of the abstract supporting the evidence
ALL_TEXT_1/3
Number of the section of the abstract supporting the evidence
1
Number of the sentence supporting the evidence
1
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00407162808120455
Drugs